Our Posts

In 2023, Sarah Callahan's son, Rudy, was diagnosed with lead poisoning after consuming WanaBana apple cinnamon fruit purée pouches. The FDA reported 52 similar cases across 25 states, with some pouches containing 200 times the proposed lead limit. WanaBana recalled the product, and Dollar Tree worked to remove it from shelves. The FDA plans to finalize guidelines by 2025, but current regulations allow action against unsafe products. Legal recourse, such as product liability lawsuits, is available for affected families. Parker Waichman LLP offers free consultations for those impacted.

Ozempic, a diabetes medication also used for weight loss, is under scrutiny due to reported adverse side effects, including stomach paralysis and severe burning pain. Maria E. Rosas, a Texas-based professor, switched to Ozempic for her type 2 diabetes in April 2023. Initially, she experienced stable glucose levels, but later suffered intense burning pain and skin issues. Her doctor advised discontinuing Ozempic, and she reported her side effects to the Ozempic hotline and FDA. Rosas is currently not on any diabetes medication and is managing her condition through diet.

The FDA is investigating hospitalizations and deaths linked to counterfeit semaglutide drugs, including Ozempic. Reports indicate that at least three people in the U.S. were hospitalized after using fake versions, which replaced semaglutide with synthetic insulin. Over 42 cases have been reported, with more than half deemed serious, including fatalities. Novo Nordisk, Ozempic's manufacturer, is working with the FDA to raise awareness about these counterfeit products. The demand for Ozempic, driven by its weight loss effects, has led to shortages and increased fraud. Legal action is advised for those harmed by counterfeit drugs.

The FDA has issued a warning about brominated vegetable oil (BVO), a common additive in citrus-flavored soft drinks, due to its potential toxicity to thyroid health. Studies by the NIH indicate BVO's harmful effects, including risks to the thyroid and nervous system. Although many beverage companies have removed BVO from their products, it remains in some drinks. The FDA is considering banning BVO, with a decision expected after January 17, 2024, following public feedback and further analysis.

In Farmingdale, New York, as the holiday season approaches, law enforcement and Long Island parents are highlighting the dangers of impaired driving. These parents, who have lost children to DWI incidents, are advocating for stricter laws to prevent further tragedies. They share their stories to emphasize the severe consequences of impaired driving. Current laws have loopholes that hinder arrests for drugged driving, as officers must identify the specific drug causing impairment. Families plan to push for legislative changes to address these issues and enhance road safety.

A salmonella outbreak linked to cantaloupes has led to an urgent recall after two deaths and numerous hospitalizations in the U.S. and Canada. Nearly 100 people in the U.S. and 63 in Canada have been affected. Companies like Crown Jewels Produce and ALDI have recalled cantaloupes, with distribution across many states and provinces. Consumers are advised to avoid these products and seek medical help if needed. Legal action may be pursued for compensation, with Parker Waichman LLP offering free consultations for affected individuals.

In a landmark case, two Gree USA executives were convicted for not disclosing defects in dehumidifiers linked to house fires across the U.S. This marks the first corporate criminal enforcement under the Consumer Product Safety Act. The faulty dehumidifiers, sold under brands like Frigidaire and GE, caused over 450 fires. Executives Simon Chu and Charley Loh face up to five years in prison. Gree USA must pay a $500,000 fine as part of a $91 million settlement. The CPSC has issued a recall for these dangerous products.

Lenovo has recalled its USB-C Laptop Power Banks due to a fire hazard from a manufacturing defect where internal screws can loosen, causing a short circuit and battery overheating. The recall affects about 2,850 units in the U.S. and 510 in Canada, manufactured between January and June 2022. Consumers should stop using the power banks and contact Lenovo for a free replacement. Legal options are available for those affected, with Parker Waichman LLP offering free consultations for potential product liability claims.

The U.S. Consumer Product Safety Commission (CPSC) has issued a warning to stop using Miracle Baby Loungers due to suffocation and fall risks. Manufactured by Yichang Lanqier Garment Co. Ltd. and sold on Amazon, these loungers do not meet federal safety standards. Despite a Notice of Violation, the company has not recalled the product. Consumers are advised to dispose of the loungers. Affected families may consider legal action for damages. Parker Waichman LLP offers free consultations for those impacted.

The Consumer Product Safety Commission has issued a recall for approximately 7,500 Red Shed Hammock Swing Chairs sold at Tractor Supply due to a defect in the plastic buckle, which can break and cause falls. These chairs, sold from April to June 2023, feature blue and silver mesh fabric with black straps. Customers should stop using the chairs and return them for a refund. Victims of injuries may consider legal action for compensation. Parker Waichman LLP offers free consultations for affected individuals.

The nationwide recall of Apple Cinnamon Fruit Puree pouches due to lead contamination has raised health concerns, particularly for children under four. Despite the recall, the FDA found the product still being sold at Dollar Tree stores. The recall was initiated after a toddler in North Carolina was found with high blood lead levels. Manufactured in Ecuador, the puree is sold under brands like WanaBana. The FDA is working to ensure the product's removal from shelves and advises proper disposal. Legal actions are being considered for affected families seeking compensation.

The U.S. Consumer Product Safety Commission (CPSC) has issued a safety alert for Miracle Baby Loungers sold on Amazon, citing risks of suffocation and falls due to design flaws and inadequate labeling. Consumers are advised to stop using and dispose of these loungers immediately. Despite a Notice of Violation, the seller has not initiated a recall. Legal action may be pursued by affected individuals. Parker Waichman LLP offers free consultations for those seeking compensation for injuries related to these loungers.

Worthington Industries has recalled approximately 121,100 Balloon Time Mini Helium Tanks due to a safety risk where compressed helium may leak, causing the plastic cap to eject and pose an injury hazard. Consumers are advised to stop using the tanks, release the helium safely, and mark the tanks for a refund. The tanks, sold from April to October 2023, can be identified by their red label and purple cap. Affected individuals may consider legal action for injuries, with Parker Waichman LLP offering free consultations for potential lawsuits.

Honda has recalled 248,999 vehicles, including various Honda and Acura models, due to a defect in the V-6 engines that could cause significant engine damage. The issue involves improperly ground crank pins, leading to potential engine failure. Symptoms include unusual noises, stalling, and reduced power. Affected models include the 2015-2020 Acura TLX, 2016-2020 Acura MDX, 2016-2019 Honda Pilot, 2018-2019 Honda Odyssey, and 2017 and 2019 Honda Ridgeline. Owners will be notified by mail starting January 2, 2024, for free inspections and repairs.

Dr. James Kelly of Kelly Vision Center has highlighted concerns about drug-resistant bacteria in certain eye drops, coinciding with the FDA's recall of 27 products due to contamination risks. The recalls, affecting brands like CVS and Target, stem from unsanitary manufacturing conditions. Dr. Ronald Benner of the AOA stresses the importance of safe manufacturing practices and advises those affected to seek medical attention. Consumers are urged to consult optometrists before using over-the-counter eye drops and to follow FDA guidelines for disposing of recalled products.

The U.S. FDA has identified significant sanitation and production issues at Kilitch Healthcare India's plant in Mumbai, leading to a recall of over two dozen eye drop varieties sold by major U.S. retailers. The FDA inspection revealed inadequate protective gear use, facility deterioration, and manipulation of contamination test results. Despite no reported adverse events, the FDA warns of potential vision loss risks. The recall highlights challenges in overseeing international pharmaceutical supply chains, exacerbated by reduced inspections during the COVID-19 pandemic. Retailers like CVS have responded by halting sales and offering refunds.

The FDA has issued a Class I recall for the Asensus Surgical Senhance robot due to a malfunction causing uncontrolled movement, specifically the laparoscope instrument actuator rotating uncontrollably. No patient harm has been reported, but there is a risk of severe tissue damage. The recall affects five devices in the U.S., and users are advised to stop using them until a software update is applied. The Senhance system, approved in 2017, features advanced technology and has been involved in various collaborations. Asensus is also developing a new surgical robot, Luna, expected to gain FDA clearance by 2025.

The FDA issued a warning to Amazon, leading to the removal of seven eye drop brands from its platform. These products were marketed as treatments for conditions like pink eye and cataracts, classifying them as "new drugs" needing FDA approval, which they lacked. The affected brands include Similasan Pink Eye Relief and Can-C Eye Drops. Amazon is removing these products, emphasizing compliance with laws. This follows previous FDA warnings about eye drops due to contamination risks, prompting recalls by CVS, Rite Aid, and others.

A federal judge in the U.S. has allowed lawsuits against major social media companies, including Alphabet, Meta, ByteDance, and Snap, for allegedly addicting young users and causing mental health issues. Judge Yvonne Gonzalez Rogers dismissed the companies' attempts to stop the litigation, which involves claims from children suffering from depression, anxiety, and other health problems. The ruling also aligns with actions by school districts and states. The judge emphasized the companies' duty to design safe products and dismissed certain claims related to third-party content.

Recent research published in Environmental Health Perspectives highlights a significant link between common pesticide exposure and reduced sperm counts in men worldwide. This trend, observed since the 1970s, raises concerns about fertility and broader public health issues, such as increased testicular cancer rates. The study, a meta-analysis of 20 studies involving 1,774 men, found a strong association between exposure to organophosphates and N-methyl carbamates and decreased sperm density. However, direct causation remains unproven, necessitating further research to fully understand the impact of these chemicals on male fertility.

As the holiday season approaches, parents are urged by the Consumer Product Safety Commission (CPSC) to prioritize toy safety. The CPSC's report highlights a 16% decrease in toy-related injuries but notes 11 fatalities and 145,500 emergency visits in 2022. Choking hazards and non-motorized scooters are major concerns. Parents should follow age guidelines, use safety gear, and keep small objects away from young children. Caution is advised when purchasing toys online. Legal action for toy-related injuries may be pursued, with Parker Waichman LLP offering free consultations for affected families.

The FDA has issued a Class I recall for over 32 million Cardinal Health Monoject syringes due to compatibility issues with syringe pumps, posing risks of overdosing, underdosing, and therapy delays. The recall affects syringes distributed between June and August 2023. Cardinal Health has reported multiple incidents of therapy delays and inaccurate dispensing. Victims may seek legal action for damages under product liability law. Parker Waichman LLP offers free consultations for those affected, providing legal guidance and support in pursuing compensation and holding manufacturers accountable.

Judith Gregory, 81, from Kentucky, filed a lawsuit against Global Pharma Healthcare, claiming their EzriCare Artificial Tears caused her severe eye infection. The product was recalled due to bacterial contamination, linked to blindness and fatalities. The FDA warned against multiple eye drop brands, highlighting regulatory gaps in non-prescription drugs. A study by Timothy Milton Janetos emphasized these oversight issues. The FDA and CDC are working to improve safety standards, with proposed legislative changes to enhance manufacturing inspections. Eye care professionals urge consumers to stay informed about recalls.

A legislative effort in the U.S. aims to ban water beads, small polymer spheres that expand in water, due to child injuries and a death. Congressman Frank Pallone Jr. plans to introduce a bill for a nationwide ban, supported by the Consumer Product Safety Commission (CPSC). Water beads, often mistaken for candy, pose ingestion risks, causing severe health issues. The CPSC recorded 7,800 emergency visits from 2016-2022. The proposed 'Ban Water Beads Act' seeks to protect children by removing these products from the market.